No More Ouch! Vaccine Delivery is Changing
This article was originally published in Start Up
Since the mid-1950's getting "shots" has been a source of childhood terror. Now, small companies are looking at ways to deliver vaccines through the oral or nasal mucosa, or using needle-free skin delivery systems to take advantage of immune cells within the skin.
You may also be interested in...
Oxagen's goal is to use large familial clinical groups and sample banks to identify disease genes through agreements with three groups of academic clinical investigators, located throughout Europe.
PolyGenomics was spun-out of Yale University to develop a genetic amplification technology in the search for genes implicated in psychiatric illnesses.
Genome Pharmaceuticals of Germany is a full-service genomics company that claims "one-top shopping" for target identification.